Adaptive Biotechnologies Corporation (ADPT) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
ADPT Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Adaptive Biotechnologies Corporation (ADPT) trades at a price-to-earnings ratio of -37.7x, with a stock price of $14.69 and trailing twelve-month earnings per share of $-0.32.
Compared to the Healthcare sector median P/E of 22.3x, ADPT trades at a 269% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, ADPT trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ADPT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ADPT P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $21B | 25.5Lowest | 6.01Best | +171%Best | |
| $3B | 49.7 | - | +165% | |
| $176B | 26.8 | 12.67 | +7% | |
| $124B | 34.9 | - | -5% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
See ADPT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ADPT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ADPT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonADPT — Frequently Asked Questions
Quick answers to the most common questions about buying ADPT stock.
Is ADPT stock overvalued or undervalued?
ADPT current P/E: -37.7x. 5-year average P/E: N/A. Percentile: N/A.
How does ADPT's valuation compare to peers?
Adaptive Biotechnologies Corporation P/E of -37.7x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is ADPT's PEG ratio?
ADPT PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.